Glucose Levels and Outcomes in Women - Mid Pregnancy

Part of paid clinical trials in Fargo, North Dakota.

Sponsor
Sanford Health
Study ID
NCT07598149
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Pregnancy

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

Up to 75% of reproductive age women are overweight, 40% are considered obese, and the prevalence of gestational diabetes mellitus (GDM) continues to rise, from 6% to 8.3% between 2016 and 2021. Currently understood GDM risk factors, such as advanced maternal age, prior history of GDM, family history of diabetes, and socioeconomic status can only explain up to 50% of cases. Related factors such as body image dissatisfaction, eating behaviors, and daily stress exposure have been linked to blood sugar metabolization, pregnancy outcomes, and the normative physiological changes that occur during pregnancy. These interrelated mechanisms may serve as additional risk factors that could help identify other women at risk of GDM. This project aims to investigate how body image dissatisfaction, eating behaviors, and daily stress exposure are associated with the metabolization of blood sugar during pregnancy. In this study the Strahm Lab will recruit 50 pregnant women to participate in a study assessing blood sugar metabolization as it is related to stress, body image dissatisfaction, and eating behaviors. The study will use continuous glucose monitoring in concert with an ecological momentary assessment protocol to assess these interrelated factors over the course of 10 days between 14 and 28 weeks gestation.

Key Dates

Start date
May 31, 2026
Status verified
May 2026
Primary completion
May 31, 2027
Completion
May 31, 2028

Study Design

Enrollment
50 participants (estimated)

Primary Outcome Measure

Continuous Blood Glucose via Dexcom G7 [ Time Frame: 10 days ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
North Dakota State UniversityFargoNorth Dakota58102
Grace Biermann, MPH
[email protected]
605-312-6457
Clayton J. Hilmert, PhD (SUB_INVESTIGATOR)
Sanford HealthFargoNorth Dakota58104
Grace Biermann, MPH
[email protected]
605-312-6457
Anna M. Strahm, PhD (PRINCIPAL_INVESTIGATOR)
Sanford HealthSioux FallsSouth Dakota57104
Grace Biermann, MPH
[email protected]
605-312-6457
Anna M. Strahm, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Fargo, ND

By research site
North Dakota State University· Fargo, NDSanford Health· Fargo, NDSanford Health· Sioux Falls, SD

Related Studies